GLP-1 Medications and Cancer Risk: What a New Study Shows
GLP-1 Medications and Cancer Risk: What a New Study Shows Published May 26, 2026 | Dr. Ethan Lazarus, MD A new study…
Comprehensive Medical Weight Loss Denver
Expert Advice and Updates on Medical Weight Loss
Protein on GLP-1s: How to Eat to Preserve Muscle and Keep Losing Fat | Denver
A patient came in last month frustrated. She’d been on a GLP-1 medication for four months, had lost 18 pounds — and…
Why Your GLP-1 Might Not Be Working — and What a Medical Team Can Actually Do About It
For years, the standard answer was: eat less, move more. If that didn’t work, you didn’t try hard enough. We know better…
5 GLP-1 Mistakes Patients Make (And How to Avoid Them)
If you’re on a GLP-1 medication—or thinking about starting one—you owe it to yourself to get this right. These drugs work. But…
Survodutide Phase 3: 16.6% Weight Loss in Adults with Obesity
New Phase 3 Data: Survodutide Delivers 16.6% Weight Loss — Dual GLP-1/Glucagon Agonist Shows Metabolic Benefits Beyond the Scale The SYNCHRONIZE-1 Phase…
Amazon’s GLP-1 Program: Is Convenience Enough?
Amazon just entered the weight loss drug business. And if you’ve been watching the GLP-1 space, you probably saw it coming. On…
GLP-1 Drugs Help Your Liver Before Weight Loss: Denver Research
For years, the prevailing assumption was simple: GLP-1 drugs help the liver because they help you lose weight. Cut calories, shed pounds,…
Foundayo vs. Oral Wegovy vs. Zepbound: Making Sense of the GLP-1 Options
Not all GLP-1s are the same. And for the first time in this drug class, you actually have real choices. With orforglipron…
Retatrutide: What Lilly’s Triple-Agonist Drug Means for Weight Loss Treatment
Let me start with a number that should get your attention: 28.7%. That’s how much body weight participants lost in the latest…
